Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
AFT Pharmaceuticals Ltd. ( (NZ:AFT) ) has issued an announcement.
AFT Pharmaceuticals has declared a final dividend for FY26, reflecting continued profitability and a commitment to returning capital to shareholders. The total cash distribution amounts to NZ$2.62 million, funded from retained earnings and income available for distribution, and will be paid on 3 July 2026 to shareholders on record as of 19 June 2026.
The dividend is fully imputed at 28%, providing tax credits to eligible New Zealand investors and underscoring AFT’s stable earnings and established position in the local capital market. The announcement signals ongoing confidence in the company’s financial performance and offers income-focused shareholders a predictable return, although no dividend reinvestment plan is attached to this distribution.
More about AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Limited is a New Zealand-based pharmaceutical company listed on the NZX under the ticker AFT. It focuses on developing, licensing, and distributing pharmaceutical products, with a portfolio that includes over-the-counter and prescription medicines targeting both domestic and international markets.
Average Trading Volume: 12,589
Technical Sentiment Signal: Buy
Current Market Cap: N$364.9M
See more data about AFT stock on TipRanks’ Stock Analysis page.